New SEC Form D filing

Renovare Therapeutics, Inc., 2026-10-02

A new SEC Form D private-offering notice from Boulder, CO, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Renovare Therapeutics, Inc. site↗ Verified via SEC Form D

Biotech developing regenerative cartilage and bone therapies for osteoarthritis using gene therapy, controlled drug delivery, and advanced biomaterials platforms

New filing todayFiled to raise $1,000,000First money in 2026-09-14Raised so far $100,000HQ (as filed) Boulder, COSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified renovaretx.com↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source